GE Healthcare’s AIR Recon DL Receives FDA Clearance of 3D & Motion-Insensitive Imaging Applications for Next-Level Image Quality and Patient Experience in MRI
29 Septiembre 2022 - 10:00AM
Business Wire
- Extending deep learning-based AIR Recon DL compatibility to 3D
& PROPELLER has the potential to enable more confident patient
diagnoses in MRI
GE Healthcare announced US FDA 510(k) clearance of its
breakthrough AIR Recon DL for 3D and PROPELLER imaging sequences1.
The benefits of AIR Recon DL are extended by these new features to
nearly all Magnetic Resonance Imaging (MRI) clinical procedures,
covering all anatomies and enabling better image quality, shorter
scan times, and enhanced patient experience.
Already, GE Healthcare’s AIR Recon DL deep learning-based image
reconstruction technology for MRI has fundamentally shifted the
balance between image quality and scan time. Now, with the
solution’s expanded compatibility from 2D to 3D imaging sequences,
physicians can quickly and confidently diagnose patients with
improved signal-to-noise ratio (SNR) and sharpness. 3D imaging
provides for more clinical efficiency, allowing radiologists to
eliminate the need for multiple 2D acquisitions - potentially
leading to faster diagnosis.
Additionally, AIR Recon DL is now compatible with PROPELLER, a
motion-insensitive imaging sequence particularly important for
anatomies susceptible to motion such as respiration during MRI
exams, as well as pediatric, neurodegenerative, geriatric, and
claustrophobic patients who have difficulty remaining physically
still for the duration of an MRI scan. As a result, physicians can
get sharper images without the need for repeat scans – translating
to faster patient throughput, improved scheduling, shorter exam
time, and faster diagnosis, helping to create an all-round better
patient experience.
As of September 2022, at least 3.5 million patients globally
have been scanned with AIR Recon DL. According to a recent AIR
Recon DL 3D and PROPELLER reader study:
- 100% of the participants said that the deep learning solution
provides better signal-to-noise ratio and better or equivalent
image sharpness than conventional image reconstruction;
- 99% also said AIR Recon DL provides better or equivalent lesion
conspicuity; and
- Reports also indicate up to 50% reduction in exam times,
creating efficiency in workflow and increased productivity2.
“By expanding AIR Recon DL to 3D and PROPELLER, GE Healthcare
has closed the gaps in our ability to provide improved image
quality and patient experience to all our patients across exam
types, particularly for brain imaging where we rely heavily on 3D
sequences and musculoskeletal imaging where PROPELLER is important
for reducing image quality variability and eliminating repeat
sequences due to motion,” says Dr. Tiron Pechet, Radiologist and
Assistant Medical Director at Shields Health Care Group.
AIR Recon DL and the recent extensions are available on new GE
Healthcare MRI scanners, and as an upgrade for the vast majority of
GE Healthcare’s installed 1.5T and 3.0T MRI systems. Beyond its
efficiency and productivity benefits to the industry, this upgrade
will enable previously installed scanners to refresh and function
like new systems – allowing imaging facilities to enjoy the most
advanced imaging capabilities on their existing systems, while
saving on capital expenditure amid today’s cost constrained
environment.
About GE Healthcare:
GE Healthcare is the $17.7 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology, pharmaceutical
diagnostics and digital solutions innovator, GE Healthcare enables
clinicians to make faster, more informed decisions through
intelligent devices, data analytics, applications and services,
supported by its Edison intelligence platform. With over 100 years
of healthcare industry experience and around 48,000 employees
globally, the company operates at the center of an ecosystem
working toward precision health, digitizing healthcare, helping
drive productivity and improve outcomes for patients, providers,
health systems and researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights
for the latest news, or visit our website www.gehealthcare.com for
more information.
1 510(k) cleared in the USA. Not CE marked, not available for
sale in all regions.
2 GE Healthcare data on file.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220929005583/en/
Maureen Oladipo Maureen.Oladipo@ge.com +1 229 418 4479
General Electric (NYSE:GE)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
General Electric (NYSE:GE)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024